FeNO Breath Analyzer Research:CAGR of 12.8% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "FeNO Breath Analyzer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global FeNO Breath Analyzer market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for FeNO Breath Analyzer was estimated to be worth US$ 125.69 million in 2025 and is projected to reach US$ 285.79 million by 2032, growing at a CAGR of 12.80% from 2026 to 2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5512355/feno-breath-analyzer

FeNO Breath Analyzer Market Summary

The FeNO breath analyzer is a specialized medical device used to quantitatively measure the fraction of exhaled nitric oxide, assessing the level of eosinophilic inflammation in the airways and providing objective biomarkers for the diagnosis and treatment of chronic respiratory diseases such as asthma. The FeNO breath analyzer works by having the individual exhale into the device. The exhaled breath is then analyzed to determine the concentration of nitric oxide present. The results are typically available immediately or within a short period, allowing for real-time assessment and adjustment of treatment plans. It can be performed in both adults and children, making it a useful tool in managing asthma in pediatric patients as well.

According to the new market research report "Global FeNO Breath Analyzer Market Report 2026-2032", published by QYResearch, the global FeNO Breath Analyzer market size is projected to reach USD 286 million by 2032, at a CAGR of 12.8% during the forecast period.

Figure00001. Global FeNO Breath Analyzer Market Size (US$ Million), 2021-2032

FeNO Breath Analyzer

Above data is based on report from QYResearch: Global FeNO Breath Analyzer Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.

Figure00002. Global FeNO Breath Analyzer Top 8 Players Ranking and Market Share (Ranking is based on the revenue of 2025, continually updated)

FeNO Breath Analyzer

Above data is based on report from QYResearch: Global FeNO Breath Analyzer Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of FeNO Breath Analyzer include NIOX Group (Circassia AB), CAIRE (Niterra), Bosch Healthcare Solutions, Bedfont Scientific, ECO PHYSICS AG, etc.

In 2025, the global top five players had a share approximately 86% in terms of revenue.

Figure00003. FeNO Breath Analyzer, Global Market Size, Split by Product Segment

FeNO Breath Analyzer

Based on or includes research from QYResearch: Global FeNO Breath Analyzer Market Report 2026-2032.

Desktop FeNO breath analyzers are typically deployed in respiratory and pediatric departments of tertiary hospitals, as well as in research institutions, and are positioned as "high-performance airway inflammation detection platforms." Represented by models such as the ANALYZER CLD 88 sp from Switzerland's ECO PHYSICS, these devices employ chemiluminescence nitric oxide analysis technology. They can continuously and synchronously display nitric oxide concentration, flow rate, and volume during the breathing process.

Handheld FeNO breath analyzers are designed around "point-of-care testing" and "convenient follow-up," targeting settings such as respiratory clinics, allergy specialists, and home use. The NO breath from the UK's Bedfont Scientific is described as a nitric oxide device for asthma diagnosis and management, emphasizing its completely non-invasive and simple operation suitable for both adult and pediatric patients.

In terms of product type, currently Desktop is the largest segment, hold a share of 83.4%.

FeNO is available in both online and offline testing methods. Both online and offline methods have the same requirements for pressure and flow rate, both requiring an expiratory pressure of 5 cmH2O (1 cmH2O = 0.098 kPa) thus closing the soft palate and avoiding upper airway effects.

The expiratory flow rate was 50 mL/s, which was maintained within a flow rate range of ±10%. Exhalation time was at least 4 s (≤12 years, child mode), and offline method could be used in children aged 3 years and above if they could not cooperate with the online method for FeNO determination.

The online method requires one breath exhalation to be completed for at least 6 s (>12 years, adult mode), while the offline method is a multi-breath measurement with no requirement for exhalation time, and adults can exhale multiple times until sampling is complete.

In terms of product application, currently Adults is the largest segment, hold a share of 64.6%.

Market Trends

The FeNO breath analyzer is a dedicated medical device used to measure the fractional exhaled nitric oxide, which reflects the level of type II airway inflammation and aids in the diagnosis and management of respiratory diseases such as bronchial asthma.

In terms of product form, the industry is evolving from early desktop chemiluminescence analyzers to a landscape dominated by portable, handheld, and point-of-care testing devices. The NIOX VERO, launched by the UK-based NIOX Group, is positioned by the company as the "gold standard in FeNO technology" and supports bedside testing in primary care clinics and specialized centers. Bedfont's NObreath is also a handheld FeNO device, described as widely used in general practice and respiratory clinics across the UK.

FeNO is rapidly expanding from a "specialist tool" to primary care, pediatric clinics, and community management. NIOX and Bedfont consistently publish guideline interpretations, online courses, and remote training content on their official websites and educational platforms to enhance physicians' understanding of FeNO's role in identifying asthma phenotypes and stratifying biologic therapy.

Market Challenges

For certain populations, it is not recommended as a routine tool for predicting future asthma, and the guidelines repeatedly emphasize that FeNO should not be used in isolation for making management decisions. A Chinese multicenter pediatric study also indicated that, compared to the cutoff values recommended by the American ATS, local reference intervals show differences in efficacy assessment.

The NIOX VERO utilizes a pre-calibrated sensor, which requires periodic replacement of the sensor module. The NO breath device relies on disposable mouthpieces and regular maintenance. For primary care institutions with limited resources, the combined costs of equipment procurement, consumables, and training can slow the pace of adoption.

Market Drivers

The ATS guidelines systematically summarize the application scenarios of FeNO in airway inflammation assessment and inhaled corticosteroid treatment monitoring. These authoritative documents collectively reinforce the status of FeNO as a biomarker for type II inflammation, providing a medical basis for device deployment worldwide.

The demand for refined asthma management and personalized medication has created significant commercial opportunities. For example, Bedfont's collaboration with the American Allergy Partners network has led to the deployment of NO breath devices in over a hundred allergy and asthma clinics as part of their standard workflow, optimizing patient stratification and management.

Chinese domestic manufacturers, such as Sunvou Medical Electronics and e-LinkCare Meditech, have launched locally registered FeNO analyzers targeting respiratory specialty departments and health examination institutions. With advancements in portable design, battery power, and Bluetooth connectivity, FeNO testing is expanding into home monitoring, remote follow-up, and digital asthma management platforms, opening up opportunities for collaboration between device manufacturers and digital health companies.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The FeNO Breath Analyzer market is segmented as below:
By Company
NIOX Group (Circassia AB)
CAIRE (Niterra)
Bosch Healthcare Solutions
Bedfont Scientific
ECO PHYSICS AG
Sunvou Medical Electronics
e-LinkCare Meditech
Hefei Micro Valley Medical

Segment by Type
Desktop
Handheld

Segment by Application
Children
Adults

Each chapter of the report provides detailed information for readers to further understand the FeNO Breath Analyzer market:

Chapter 1: Introduces the report scope of the FeNO Breath Analyzer report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of FeNO Breath Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various FeNO Breath Analyzer market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of FeNO Breath Analyzer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of FeNO Breath Analyzer in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth FeNO Breath Analyzer competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides FeNO Breath Analyzer comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides FeNO Breath Analyzer market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global FeNO Breath Analyzer Market Outlook, In‐Depth Analysis & Forecast to 2032
Global FeNO Breath Analyzer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global FeNO Breath Analyzer Market Research Report 2026

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.